AstraZeneca: At first glance, 2013 is ok but 2014 should (again) require downward adjustments

NEUTRAL, Fair Value  3830p (-1%)

News published on February Thursday 6, 2014
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities